SHOCKWAVE MEDICAL INC (SWAV) Stock Price & Overview

NASDAQ:SWAV • US82489T1043

Current stock price

334.75 USD
-0.08 (-0.02%)
At close:
334.8 USD
+0.05 (+0.01%)
After Hours:

The current stock price of SWAV is 334.75 USD. Today SWAV is down by -0.02%. In the past month the price increased by 1.49%. In the past year, price increased by 15.77%.

SWAV Key Statistics

52-Week Range157 - 334.9
Current SWAV stock price positioned within its 52-week range.
1-Month Range329.5 - 334.9
Current SWAV stock price positioned within its 1-month range.
Market Cap
12.567B
P/E
78.21
Fwd P/E
53.09
EPS (TTM)
4.28
Dividend Yield
N/A

SWAV Stock Performance

Today
-0.02%
1 Week
+0.22%
1 Month
+1.49%
3 Months
+27.08%
Longer-term
6 Months +83.73%
1 Year +15.77%
2 Years +103.86%
3 Years +86.08%
5 Years +459.88%
10 Years N/A

SWAV Stock Chart

SHOCKWAVE MEDICAL INC / SWAV Daily stock chart

SWAV Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to SWAV. When comparing the yearly performance of all stocks, SWAV is one of the better performing stocks in the market, outperforming 87.72% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

SWAV Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to SWAV. SWAV has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SWAV Earnings

On May 6, 2024 SWAV reported an EPS of 1.44 and a revenue of 218.81M. The company beat EPS expectations (44.66% surprise) and beat revenue expectations (3.29% surprise).

Next Earnings DateAug 5, 2024
Last Earnings DateMay 6, 2024
PeriodQ1 / 2024
EPS Reported$1.44
Revenue Reported218.805M
EPS Surprise 44.66%
Revenue Surprise 3.29%

SWAV Forecast & Estimates

16 analysts have analysed SWAV and the average price target is 330.75 USD. This implies a price decrease of -1.19% is expected in the next year compared to the current price of 334.75.

For the next year, analysts expect an EPS growth of 36.11% and a revenue growth 27.69% for SWAV


Analysts
Analysts53.75
Price Target330.75 (-1.19%)
EPS Next Y36.11%
Revenue Next Year27.69%

SWAV Groups

Sector & Classification

Index Membership

SWAV Financial Highlights

Over the last trailing twelve months SWAV reported a non-GAAP Earnings per Share(EPS) of 4.28. The EPS increased by 12.34% compared to the year before.


Income Statements
Revenue(TTM)787.98M
Net Income(TTM)163.55M
Industry RankSector Rank
PM (TTM) 20.76%
ROA 9.95%
ROE 21.76%
Debt/Equity 0.97
Chartmill High Growth Momentum
EPS Q2Q%39.81%
Sales Q2Q%35.85%
EPS 1Y (TTM)12.34%
Revenue 1Y (TTM)41.44%

SWAV Ownership

Ownership
Inst Owners10.85%
Shares37.54M
Float37.06M
Ins Owners5.23%
Short Float %N/A
Short RatioN/A

About SWAV

Company Profile

SWAV logo image Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company is headquartered in Santa Clara, California and currently employs 1,001 full-time employees. The company went IPO on 2019-03-07. The firm is focused on development and commercialization of products intended to transform the way calcified cardiovascular disease is treated. The company provides care for the treatment of calcified cardiovascular disease through its differentiated local delivery of sonic pressure waves, intravascular lithotripsy (IVL). Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. Its Shockwave L6 IVL catheter is a six-emitter catheter for use in its IVL System in large diameter vessels for the treatment of PAD. Its Shockwave C2 IVL catheter and Shockwave C2+ IVL catheter are two-emitter catheters for use in its IVL System for the treatment of coronary artery disease (CAD).

Company Info

IPO: 2019-03-07

SHOCKWAVE MEDICAL INC

5403 Betsy Ross Dr

Santa Clara CALIFORNIA 95054 US

CEO: Douglas Godshall

Employees: 1001

SWAV Company Website

Phone: 15102794262

SHOCKWAVE MEDICAL INC / SWAV FAQ

What does SWAV do?

Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company is headquartered in Santa Clara, California and currently employs 1,001 full-time employees. The company went IPO on 2019-03-07. The firm is focused on development and commercialization of products intended to transform the way calcified cardiovascular disease is treated. The company provides care for the treatment of calcified cardiovascular disease through its differentiated local delivery of sonic pressure waves, intravascular lithotripsy (IVL). Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. Its Shockwave L6 IVL catheter is a six-emitter catheter for use in its IVL System in large diameter vessels for the treatment of PAD. Its Shockwave C2 IVL catheter and Shockwave C2+ IVL catheter are two-emitter catheters for use in its IVL System for the treatment of coronary artery disease (CAD).


Can you provide the latest stock price for SHOCKWAVE MEDICAL INC?

The current stock price of SWAV is 334.75 USD. The price decreased by -0.02% in the last trading session.


Does SHOCKWAVE MEDICAL INC pay dividends?

SWAV does not pay a dividend.


How is the ChartMill rating for SHOCKWAVE MEDICAL INC?

SWAV has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Can you provide the number of employees for SHOCKWAVE MEDICAL INC?

SHOCKWAVE MEDICAL INC (SWAV) currently has 1001 employees.


What is the market capitalization of SWAV stock?

SHOCKWAVE MEDICAL INC (SWAV) has a market capitalization of 12.57B USD. This makes SWAV a Large Cap stock.